Case Report
BibTex RIS Cite

F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up

Year 2022, Volume: 2 Issue: 1, 1 - 2, 15.04.2022

Zehra Pınar Koç Pınar Pelin Özcan Emel Sezer Gökçe Yavan

Abstract

Ameloblastoma is a benign odontogenic tumor that originate from dental region (1). Previous reports have determined the F-18 FDG PET/CT findings of this tumor (1) and this is the first case with follow up results in the literature as far as we know.

Keywords

Ameloblastoma FDG PET/CT Treatment Responce

References

  • Seno S, Kitajima K, Inokuchi G, Nibu K, Itoh T, Ejima Y, Sasaki R, Sugimoto K, Sugimura K. FDG-PET findings of Ameloblastoma: a case report. Springerplus. 2015;4:250.
  • Inoue N, Shimojyo M, Iwai H, Ohtsuki H, Yasumizu R, Shintaku M, Taniguchi N, Inada M, Arika T, Morita S, et al. Malignant ameloblastoma with pulmonary metastasis and hypercalcemia. Report of an autopsy case and review of the literature. Am J Clin Pathol. 1988;90(4):474-81
  • Devenney-Cakir B, Dunfee B, Subramaniam R, Sundararajan D, Mehra P, Spiegel J, Sakai O. Ameloblastic carcinoma of the mandible with metastasis to the skull and lung: advanced imaging appearance including computed tomography, magnetic resonance imaging and positron emission tomography computed tomography. Dentomaxillofac Radiol. 2010;39(7):449-53Iban, M. C. (2020). Geospatial data science response to COVID-19 crisis and pandemic isolation tracking. Turkish Journal of Geosciences, 1(1), 1-7.
  • Nguyen BD. Malignant ameloblastoma with thoracic vertebral metastasis: PET/CT and MR imaging. Clin Nucl Med. 2005 Jun;30(6):450-2Yakar, M., Yılmaz, H. M., & Mutluoglu, O. (2014). Performance of photogrammetric and terrestrial laser scanning methods in volume computing of excavation and filling areas. Arabian Journal for Science and Engineering, 39, 387-394.
  • Otsuru M, Aoki T, Tsukinoki K, Ota Y, Karakida K, Yamazaki H, Yasuda M, Kaneko A. Usefulness of 18F-fluorodeoxyglucose positron emission tomography for detecting ameloblastoma, with special reference to glucose transporter-1 expression. J Oral Maxillofac Surg. 2008 Aug;66(8):1761-5.
There are 5 citations in total.

Details

Primary Language English
Subjects Oncology and Carcinogenesis
Journal Section Case Reports
Authors

Zehra Pınar Koç This is me 0000-0002-3274-5790

Pınar Pelin Özcan This is me 0000-0003-0147-2678

Emel Sezer This is me 0000-0001-9881-3533

Gökçe Yavan This is me 0000-0002-7332-6293

Publication Date April 15, 2022
Published in Issue Year 2022 Volume: 2 Issue: 1

Cite

APA Koç, Z. P., Özcan, P. P., Sezer, E., Yavan, G. (2022). F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging, 2(1), 1-2.
AMA Koç ZP, Özcan PP, Sezer E, Yavan G. F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging. April 2022;2(1):1-2.
Chicago Koç, Zehra Pınar, Pınar Pelin Özcan, Emel Sezer, and Gökçe Yavan. “F-18 FDG PET/CT Imaging in the Ameloblastoma Follow Up”. Molecular Oncologic Imaging 2, no. 1 (April 2022): 1-2.
EndNote Koç ZP, Özcan PP, Sezer E, Yavan G (April 1, 2022) F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging 2 1 1–2.
IEEE Z. P. Koç, P. P. Özcan, E. Sezer, and G. Yavan, “F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up”, Molecular Oncologic Imaging, vol. 2, no. 1, pp. 1–2, 2022.
ISNAD Koç, Zehra Pınar et al. “F-18 FDG PET/CT Imaging in the Ameloblastoma Follow Up”. Molecular Oncologic Imaging 2/1 (April 2022), 1-2.
JAMA Koç ZP, Özcan PP, Sezer E, Yavan G. F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging. 2022;2:1–2.
MLA Koç, Zehra Pınar et al. “F-18 FDG PET/CT Imaging in the Ameloblastoma Follow Up”. Molecular Oncologic Imaging, vol. 2, no. 1, 2022, pp. 1-2.
Vancouver Koç ZP, Özcan PP, Sezer E, Yavan G. F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging. 2022;2(1):1-2.